FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563295660> ?p ?o ?g. }

• W2563295660 endingPage "165" @default.
• W2563295660 startingPage "157" @default.
• W2563295660 abstract "Objective Low-grade chronic inflammation emerges as a potent driver of insulin resistance and glucose dysregulation in obesity and associated non-alcoholic fatty liver disease (NAFLD). The liver, subcutaneous fat and the immune system participate in disturbances of metabolism. Type I interferon (IFN) signalling initiated by innate and adaptive immunity modulates inflammatory responses consequent to infection. However, little is known about the role of type I IFN signalling in metabolic diseases and the development of NAFLD. Design We determined the impact of type I IFN signalling by tissue-specific deletion of interferon (α and β) receptor 1 ( Ifnar1 ) in hepatocytes ( Ifnar1 Δ hep ), adipocytes ( Ifnar1 Δ at ), intestinal epithelial cells ( Ifnar1 Δ IEC ) or myelocytes ( Ifnar1 Δ myel ) on glucose metabolism, obesity and hepatic disease in mice exposed to a high-fat or methionine-choline-deficient (MCD) diet. Furthermore, we investigated the expression of type I IFN-regulated genes in patients with obesity undergoing laparoscopic adjustable gastric banding (LAGB). Results Long chain fatty acids induce type I IFN responses in murine hepatocytes and macrophages and exposure to a high-fat diet elicited type I IFN-regulated gene expression in the liver of wild-type mice. Hepatocyte-specific, but not adipose tissue-specific deletion of Ifnar1 worsened steatosis and inflammation induced by the MCD diet. In contrast, adipose-specific, but not hepatocyte-specific deletion of Ifnar1 deteriorated metabolic dysregulation induced by a high-fat diet, indicated by increased weight gain, insulin resistance and an impaired glucose tolerance. Abrogated type I IFN signalling in myeloid or intestinal epithelial cells did not modulate susceptibility to metabolic or hepatic disease. Improved metabolic control in patients with obesity after LAGB was associated with increased expression of type I IFN-regulated genes in subcutaneous adipose tissue and liver. Conclusions Our study implicates a role for adipose and hepatocyte type I IFN signalling in diet-induced metabolic dysregulation and hepatic disease. Further studies on type I IFN signalling in metabolic diseases are warranted." @default.
• W2563295660 created "2017-01-06" @default.
• W2563295660 creator A5013439619 @default.
• W2563295660 creator A5018258721 @default.
• W2563295660 creator A5036264788 @default.
• W2563295660 creator A5043344995 @default.
• W2563295660 creator A5043360456 @default.
• W2563295660 creator A5046705548 @default.
• W2563295660 creator A5050626665 @default.
• W2563295660 creator A5057770862 @default.
• W2563295660 creator A5068637529 @default.
• W2563295660 date "2016-12-23" @default.
• W2563295660 modified "2023-10-04" @default.
• W2563295660 title "Adipose type I interferon signalling protects against metabolic dysfunction" @default.
• W2563295660 cites W1575469908 @default.
• W2563295660 cites W1579491283 @default.
• W2563295660 cites W1595293335 @default.
• W2563295660 cites W1611944043 @default.
• W2563295660 cites W1954905919 @default.
• W2563295660 cites W1967972402 @default.
• W2563295660 cites W1971209372 @default.
• W2563295660 cites W1977782677 @default.
• W2563295660 cites W1984916935 @default.
• W2563295660 cites W1995856733 @default.
• W2563295660 cites W2000177767 @default.
• W2563295660 cites W2004861205 @default.
• W2563295660 cites W2007706288 @default.
• W2563295660 cites W2009823411 @default.
• W2563295660 cites W2023629358 @default.
• W2563295660 cites W2029555937 @default.
• W2563295660 cites W2031533316 @default.
• W2563295660 cites W2040653543 @default.
• W2563295660 cites W2043348456 @default.
• W2563295660 cites W2046413321 @default.
• W2563295660 cites W2047882003 @default.
• W2563295660 cites W2049932899 @default.
• W2563295660 cites W2055656686 @default.
• W2563295660 cites W2062593620 @default.
• W2563295660 cites W2062860983 @default.
• W2563295660 cites W2067380566 @default.
• W2563295660 cites W2070352246 @default.
• W2563295660 cites W2091129202 @default.
• W2563295660 cites W2093222101 @default.
• W2563295660 cites W2095591310 @default.
• W2563295660 cites W2101316711 @default.
• W2563295660 cites W2105641909 @default.
• W2563295660 cites W2106549878 @default.
• W2563295660 cites W2112515812 @default.
• W2563295660 cites W2130495917 @default.
• W2563295660 cites W2136187101 @default.
• W2563295660 cites W2140896211 @default.
• W2563295660 cites W2141470743 @default.
• W2563295660 cites W2143104968 @default.
• W2563295660 cites W2144275312 @default.
• W2563295660 cites W2157371421 @default.
• W2563295660 cites W2165604976 @default.
• W2563295660 cites W2170037905 @default.
• W2563295660 cites W2291183286 @default.
• W2563295660 cites W2400062062 @default.
• W2563295660 cites W2508168561 @default.
• W2563295660 doi "https://doi.org/10.1136/gutjnl-2016-313155" @default.
• W2563295660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28011892" @default.
• W2563295660 hasPublicationYear "2016" @default.
• W2563295660 type Work @default.
• W2563295660 sameAs 2563295660 @default.
• W2563295660 citedByCount "52" @default.
• W2563295660 countsByYear W25632956602017 @default.
• W2563295660 countsByYear W25632956602018 @default.
• W2563295660 countsByYear W25632956602019 @default.
• W2563295660 countsByYear W25632956602020 @default.
• W2563295660 countsByYear W25632956602021 @default.
• W2563295660 countsByYear W25632956602022 @default.
• W2563295660 countsByYear W25632956602023 @default.
• W2563295660 crossrefType "journal-article" @default.
• W2563295660 hasAuthorship W2563295660A5013439619 @default.
• W2563295660 hasAuthorship W2563295660A5018258721 @default.
• W2563295660 hasAuthorship W2563295660A5036264788 @default.
• W2563295660 hasAuthorship W2563295660A5043344995 @default.
• W2563295660 hasAuthorship W2563295660A5043360456 @default.
• W2563295660 hasAuthorship W2563295660A5046705548 @default.
• W2563295660 hasAuthorship W2563295660A5050626665 @default.
• W2563295660 hasAuthorship W2563295660A5057770862 @default.
• W2563295660 hasAuthorship W2563295660A5068637529 @default.
• W2563295660 hasBestOaLocation W25632956601 @default.
• W2563295660 hasConcept C126322002 @default.
• W2563295660 hasConcept C134018914 @default.
• W2563295660 hasConcept C171089720 @default.
• W2563295660 hasConcept C202751555 @default.
• W2563295660 hasConcept C203014093 @default.
• W2563295660 hasConcept C2776175330 @default.
• W2563295660 hasConcept C2776178377 @default.
• W2563295660 hasConcept C2776200302 @default.
• W2563295660 hasConcept C2776914184 @default.
• W2563295660 hasConcept C2777180221 @default.
• W2563295660 hasConcept C2777391703 @default.
• W2563295660 hasConcept C2778772119 @default.
• W2563295660 hasConcept C2779134260 @default.
• W2563295660 hasConcept C2779306644 @default.

• next